<qa>  What is the type of disease type?Patients are stratified according to disease type cutaneous angiosarcoma scalp, breast, or soft tissue vs visceral angiosarcoma. All patients receive oral sorafenib tosylate twice daily for 9 months in the absence of disease progression or unacceptable toxicity. 